Concepts (94)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bone Neoplasms | 3 | 2017 | 30 | 1.280 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 6 | 2017 | 8 | 1.210 |
Why?
|
| Breast Neoplasms | 4 | 2017 | 69 | 1.090 |
Why?
|
| Transcription Factors | 3 | 2010 | 61 | 0.570 |
Why?
|
| Cell Movement | 2 | 2017 | 24 | 0.530 |
Why?
|
| Autophagy | 1 | 2017 | 12 | 0.510 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2016 | 9 | 0.470 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2016 | 5 | 0.470 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2017 | 32 | 0.410 |
Why?
|
| Osteoblasts | 3 | 2010 | 26 | 0.290 |
Why?
|
| Signal Transduction | 4 | 2017 | 139 | 0.260 |
Why?
|
| Animals | 6 | 2017 | 1349 | 0.260 |
Why?
|
| RNA Interference | 3 | 2017 | 10 | 0.230 |
Why?
|
| Female | 4 | 2017 | 3346 | 0.200 |
Why?
|
| Neoplasm Proteins | 1 | 2003 | 13 | 0.200 |
Why?
|
| Humans | 7 | 2017 | 5837 | 0.180 |
Why?
|
| Mice | 4 | 2016 | 465 | 0.180 |
Why?
|
| MAP Kinase Signaling System | 2 | 2016 | 12 | 0.140 |
Why?
|
| Cell Proliferation | 2 | 2016 | 43 | 0.140 |
Why?
|
| Autophagosomes | 1 | 2017 | 1 | 0.130 |
Why?
|
| Chloroquine | 1 | 2017 | 1 | 0.130 |
Why?
|
| Acetylation | 1 | 2017 | 2 | 0.130 |
Why?
|
| Tubulin | 1 | 2017 | 3 | 0.130 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2017 | 5 | 0.130 |
Why?
|
| Mice, Inbred NOD | 1 | 2017 | 5 | 0.130 |
Why?
|
| Protein Transport | 1 | 2017 | 7 | 0.130 |
Why?
|
| Microtubules | 1 | 2017 | 8 | 0.130 |
Why?
|
| Mice, SCID | 1 | 2017 | 7 | 0.130 |
Why?
|
| Cell Adhesion | 1 | 2017 | 12 | 0.130 |
Why?
|
| MCF-7 Cells | 1 | 2017 | 5 | 0.130 |
Why?
|
| Transfection | 1 | 2017 | 31 | 0.130 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 48 | 0.130 |
Why?
|
| Benzamides | 1 | 2016 | 3 | 0.120 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 13 | 0.120 |
Why?
|
| Aniline Compounds | 1 | 2016 | 10 | 0.120 |
Why?
|
| Metformin | 1 | 2016 | 4 | 0.120 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2016 | 22 | 0.120 |
Why?
|
| DNA-Binding Proteins | 2 | 2005 | 94 | 0.100 |
Why?
|
| Proteins | 2 | 2004 | 22 | 0.100 |
Why?
|
| Cell Line, Tumor | 2 | 2010 | 63 | 0.100 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2008 | 27 | 0.080 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 23 | 0.080 |
Why?
|
| Tumor Microenvironment | 1 | 2010 | 1 | 0.080 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 6 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 16 | 0.080 |
Why?
|
| Prostatic Neoplasms | 1 | 2010 | 13 | 0.080 |
Why?
|
| Cell Nucleus | 2 | 2007 | 18 | 0.080 |
Why?
|
| Transcription, Genetic | 2 | 2007 | 24 | 0.080 |
Why?
|
| Disease Progression | 1 | 2010 | 157 | 0.080 |
Why?
|
| Bone and Bones | 1 | 2010 | 74 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 2 | 2008 | 44 | 0.070 |
Why?
|
| Smad Proteins | 1 | 2008 | 1 | 0.070 |
Why?
|
| Amino Acids | 1 | 2008 | 5 | 0.070 |
Why?
|
| Cell Differentiation | 1 | 2008 | 46 | 0.070 |
Why?
|
| Neoplasms | 1 | 2007 | 39 | 0.060 |
Why?
|
| Pluripotent Stem Cells | 1 | 2005 | 1 | 0.060 |
Why?
|
| Trans-Activators | 1 | 2005 | 5 | 0.060 |
Why?
|
| Phosphoproteins | 1 | 2005 | 7 | 0.060 |
Why?
|
| Osteocytes | 1 | 2005 | 15 | 0.060 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2005 | 31 | 0.060 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2004 | 3 | 0.050 |
Why?
|
| Epitopes | 1 | 2004 | 9 | 0.050 |
Why?
|
| DNA | 1 | 2004 | 38 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 29 | 0.050 |
Why?
|
| Gene Expression | 1 | 2004 | 64 | 0.050 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2003 | 13 | 0.050 |
Why?
|
| Cell Division | 1 | 2003 | 16 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2003 | 6 | 0.050 |
Why?
|
| Down-Regulation | 1 | 2003 | 31 | 0.050 |
Why?
|
| Male | 1 | 2010 | 3399 | 0.050 |
Why?
|
| HeLa Cells | 2 | 2008 | 6 | 0.030 |
Why?
|
| Flavonoids | 1 | 2010 | 6 | 0.020 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2010 | 7 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 17 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 2010 | 27 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2010 | 37 | 0.020 |
Why?
|
| Nuclear Localization Signals | 1 | 2008 | 1 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2008 | 1 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2008 | 16 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 46 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 51 | 0.020 |
Why?
|
| Transcription Factor AP-2 | 1 | 2005 | 1 | 0.010 |
Why?
|
| Smad5 Protein | 1 | 2005 | 1 | 0.010 |
Why?
|
| Cell Lineage | 1 | 2005 | 9 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2005 | 11 | 0.010 |
Why?
|
| Mutagenesis | 1 | 2005 | 6 | 0.010 |
Why?
|
| Point Mutation | 1 | 2005 | 14 | 0.010 |
Why?
|
| Gene Deletion | 1 | 2005 | 17 | 0.010 |
Why?
|
| Kidney | 1 | 2005 | 35 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2004 | 4 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2004 | 15 | 0.010 |
Why?
|
| In Vitro Techniques | 1 | 2004 | 86 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 2004 | 30 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2004 | 24 | 0.010 |
Why?
|